Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,457 | -22,185 | -15,188 | -7,256 | -17,750 |
| Depreciation Amortization | 1,144 | 888 | 593 | 294 | 1,406 |
| Accounts payable and accrued liabilities | -1,915 | -1,695 | -2,152 | -2,110 | -702 |
| Other Working Capital | -2,655 | -2,354 | -1,462 | -1,413 | -2,406 |
| Other Operating Activity | 10,204 | 7,547 | 5,652 | 2,981 | -9,866 |
| Operating Cash Flow | $-21,679 | $-17,799 | $-12,557 | $-7,504 | $-29,318 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -713 | -595 | -582 | -191 | -88 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 28,120 |
| Investing Cash Flow | $-713 | $-595 | $-582 | $-191 | $28,032 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 24,731 |
| Debt Repayment | -10,550 | -10,550 | -10,550 | -10,550 | -22,104 |
| Common Stock Issued | 11,438 | 11,418 | 11,329 | 592 | 21,258 |
| Other Financing Activity | 25,273 | 28,369 | 31,479 | 33,900 | -11 |
| Financing Cash Flow | $26,161 | $29,237 | $32,258 | $23,942 | $23,874 |
| Beginning Cash Position | 42,534 | 42,534 | 42,534 | 42,534 | 19,946 |
| End Cash Position | 46,303 | 53,377 | 61,653 | 58,781 | 42,534 |
| Net Cash Flow | $3,769 | $10,843 | $19,119 | $16,247 | $22,588 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,679 | -17,799 | -12,557 | -7,504 | -29,318 |
| Capital Expenditure | -713 | -595 | -582 | -191 | -88 |
| Free Cash Flow | -22,392 | -18,394 | -13,139 | -7,695 | -29,406 |